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Abstract
Background: Toxoplasmosis is a zoonosis caused by Toxoplasma gondii, an intracellular protozoan parasite able to
infect a wide range of hosts, including humans. Congenital infection can cause severe damage to the fetus. Thus, it
is important to detect antibodies against the parasite to confirm clinical manifestations. Considering that all
immunoglobulin isotypes may be present in biological samples from newborns and their mothers, this study aimed
to evaluate the ability to diagnose recent toxoplasmosis by using colostrum, as an alternative noninvasive way to
obtain biological samples, as well as to determine correlation rates between antibodies from serum samples to
detect IgG, IgM and IgA isotypes against T. gondii.
Methods: A total of 289 puerperal women from Clinical Hospital of Federal University of Uberlândia (mean age:
24.8 years, range: 14 – 43 years) took part in this study. Serum and colostrum samples from these patients were
analyzed using ELISA and immunoblotting assays for soluble antigens from T. gondii.
Results: ELISA immunoassays with serum samples showed reactivity in 47.0, 6.9 and 2.8 % of samples to anti-T.
gondii IgG, IgM and IgA, respectively, in comparison with colostrum samples, which showed reactivity in 46.0, 7.9
and 2.8 % of samples to the same isotypes. Also, significant correlation rates of anti-T. gondii antibody levels
between serum and colostrum samples were observed. Interestingly, reactivity to IgM and/or IgA in colostrum and/
or serum confirmed clinical manifestations of congenital toxoplasmosis in three newborns. Immunoblotting assays
showed that it is possible to detect IgG, IgM and IgA antibodies against various antigens of T. gondii in serum and
colostrum samples. IgG antibodies in serum and colostrum samples recognized more antigenic fractions than IgM
and IgA antibodies. Serum IgG detected more antigenic fractions than IgG antibodies present in the colostrum of
the same patient. In contrast, specific IgA present in colostrum recognized a higher number of antigens than IgA
present in serum samples of the same patient.
Conclusions: Overall, the results show that it is important to investigate the occurrence of congenital
toxoplasmosis, even at puerperal period. Furthermore, this study demonstrates that T. gondii-specific IgG, IgM and
IgA antibodies in serum and colostrum samples from puerperal women may be detected with a significant
correlation, suggesting that colostrum may also be used as an alternative biological sample to efficiently diagnose
recent human toxoplasmosis.
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Background
Toxoplasmosis is an infectious disease caused by Toxo-
plasma gondii, an obligate intracellular protozoan para-
site that infects different hosts, including a third of the
human population worldwide [1, 2]. The infection is ac-
quired mainly by ingestion of water or food contami-
nated with oocysts shed in felidae feces, by ingestion of
raw meat containing tissue cysts or by congenital trans-
ference of the parasites [3]. Although, most infections
are asymptomatic in immunocompetent adults, they
may be fatal for immunocompromised patients and
cause severe damage to the fetus affected by congenital
infection [4]. The immune response against T. gondii in-
volves five isotypes of human antibodies (IgG, IgM, IgA,
IgE and IgD), specific to T. gondii, which may be de-
tected in various biological fluids, such as serum, cere-
brospinal fluid, and human colostrum or milk [5, 6].
There are several pieces of evidences showing that
breastfeeding protects the infant against a wide range of
infectious diseases [7–10] and there are currently many
studies on human milk composition to understand the
role of its bioactive components [10]. However, few efforts
have been directed to demonstrate the role of human col-
ostrum against parasitic infections, including in T. gondii
infection, as well as its use in immunodiagnosis [6].
Considering high prevalence of toxoplasmosis, and the
importance to characterize the disease in its early stage,
the present study was conducted to detect the correl-
ation of IgG, IgM and IgA antibodies with T. gondii in
paired samples of serum and colostrum, and to evaluate
the ability to diagnose this disease by using colostrum,




A total of 289 puerperal women participated in this
study. They were patients at the Obstetric Center of
the Hospital de Clínicas da Universidade Federal de
Uberlândia (UFU), Minas Gerais, Brazil, with mean age
24 years, median age 24.8 years, ranging from 14 to
43 years. The study exclusion criteria consisted of HIV
and/or HTLV seropositive women, in whom breastfeed-
ing is contra-indicated by the Brazilian Health Ministry
[11]. The study conformed to the declaration of
Helsinki, with its protocol approved by UFU Ethical
Committee (Protocol number: 104.110). A written con-
sent was obtained from each patient.
Biological samples
Human breast milk samples, volumes of 3 mL, were col-
lected between the 1st and the 3rd day postpartum, to
ensure that it was colostrum. The samples were centri-
fuged at 500 × g for 10 min at 4 °C to remove fat and
cleared colostrum samples were stored at −20 °C. Serum
samples were obtained from the patients one day after
delivery and the aliquots were stored at −20 °C.
Parasites and antigens
T. gondii RH strain tachyzoites were maintained by serial
passage in cell culture for 48–72 h, using HeLa cell lines
(ATCC/CCL-2; American Type Culture Collection,
Manassas, VA, USA), as described above [12]. Briefly,
cells were inoculated with tachyzoites of T. gondii and
maintained by serial passages in RPMI medium with 2 %
fetal bovine serum. Free parasites were collected and
washed with phosphate buffered saline (PBS, pH 7.2)
and, after addition of a protease inhibitor cocktail
(Complete Ultra tablets, Roche, USA), lysates were ob-
tained by repeated freezing and thawing cycles, sonication,
and centrifugation at 14,000 × g for 30 min at 4 °C. After
supernatant recovery, total protein was estimated by the
Bicinchoninic acid kit (BCA, Sigma, St. Louis, MO, USA)
and the aliquots were stored as soluble tachyzoite antigen
(STAg) at −80 °C until later use.
Immunoassays for detection of antibodies anti-
Toxoplasma gondii
The presence of Toxoplasma-specific IgG, IgM and IgA
antibodies was investigated in serum and colostrum
samples from puerperal women by using the Enzyme
Linked Immunosorbent Assay (ELISA) and Immuno-
bloting assays.
The optimal dilutions for serum and colostrum sam-
ples in each assay, as well as the time of incubation and
blocking conditions for these samples, were obtained by
block-titration of the reagents.
Indirect ELISA to detect anti- T. gondii IgG antibodies
ELISA to detect IgG antibodies was carried out accord-
ing to the conditions described previously [13] with
modifications. Briefly, wells of high affinity microtiter
plates (Costar Corning Incorporated, USA) were coated
with 50 μL of STAg (10 μg/mL) in 0.06 M carbonate
buffer (pH 9.6) and incubated overnight at 4 °C. Plates
were washed 3 times with PBS-Tween 0.05 % (PBS-T)
and blocked with PBS-T plus 5 % of nonfat powdered
milk (Molico, Nestlé, São Paulo, Brazil) (PBS-T-M5 %)
for 1 h at room temperature. Samples of serum (1:64 in
PBS-T-M5 %) and colostrum (1:5 in PBS-T) were incu-
bated for 1 h at 37 °C. After washing, plates were incu-
bated with goat anti-human IgG antibody labeled with
peroxidase (Sigma) for 1 h at 37 °C. The reactions were
revealed by adding peroxidase substrate system (ABTS,
KPL, Kirkegaard & Perry Laboratories), and optical
densities (OD) were determined at 405 nm. Two positive
controls and three negative controls were included in
each plate in order to calculate the cut-off, which was
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established as the mean OD values for negative controls
plus three standard deviations. Results were expressed as
ELISA index (EI), as follows: EI = ODsample/ODcut-off,
where values of EI ≥ 1.2 were considered positive [14].
Capture ELISA to detect anti- T. gondii IgM and IgA
antibodies
ELISA to detect IgM and IgA antibodies was carried out
as described previously [13] with modifications. Briefly,
high affinity microtiter plates wells were coated with ei-
ther human anti-IgM (KPL, Kirkegaard & Perry Labora-
tories) or human anti-IgA (Sigma) in 0.06 M carbonate
buffer (pH 9.6) and incubated overnight at 4 °C. Plates
were blocked with PBS-T-M5 % for 1 h at room
temperature. Samples of serum (1:16 in PBS-T-M5 %)
and colostrum (1:5 in PBS-T) were incubated for 2 h at
37 °C. After washing, plates were incubated with STAg
(100 μg/mL) diluted with PBS-T-M5 %, for 2 h at 37 °C,
followed by addition of rabbit anti-T. gondii IgG labeled
with peroxidase according to Wilson and Nakane [15].
The next steps were carried out as described above.
Immunoblotting assays to detect anti- T. gondii antibodies
Immunoblotting assays were carried out to analyze the
specificity and pattern recognition of serum and colos-
trum antibodies against STAg, as described above [16].
Briefly, STAg was separated on 12 % SDS-PAGE under
non-reducing conditions, and electrotransferred to nitro-
cellulose membranes. Non-specific interactions were
blocked by PBS-T-M5 % incubation, for 2 h at room
temperature. Nitrocellulose strips were incubated with
serum samples (diluted 1:100 [IgG] or 1:50 [IgM and IgA]
in PBS-T plus 1 % of nonfat milk – PBS-T-M1 %) or
colostrum (diluted 1:10 [IgG] or 1:5 [IgM and IgA] in
PBS-T). Protein-antibody complex was detected by in-
cubation with secondary antibodies, anti-IgG, anti-IgM
or anti-IgA labelled with peroxidase (Sigma) for 2 h at
room temperature. Reactions were revealed by adding
diaminobenzidine (Stable DAB, Invitrogen), and stopped
with distilled water. The molecular weight (KDa) for
each antigenic fraction was determined using the Image
Lab program Version 4.0.1 (Bio-Rad Laboratories,
Hercules CA).
IgG avidity immunobloting assays
After incubation with serum or colostrum samples in
duplicated nitrocellulose strips, one strip was washed
with PBS-T (urea−) and the other washed with PBS-T
containing 6 M of urea (urea+) for 10 min. After washing
with PBS-T, the strips were submitted to the immunoblot-
ting assays as described above. The intensity pixels (Int
Band) obtained for each antigenic fraction of samples were
evaluated using Image Lab program Version 4.0.1
(Bio-Rad Laboratories). The results for urea− or urea+
strips were expressed in avidity index (AI), as follows:
AI = (urea+ Int Band/urea− Int Band) × 100. AI <50 % cor-
responds to reactivity with antibodies of low avidity, while
AI > 75 % corresponds to reactivity with antibodies of high
avidity.
Statistical analysis
Statistical analysis was carried out using GraphPad
Prism 5.0 (GraphPad Software Inc., San Diego, CA). Dif-
ferences between levels of the same antibody isotypes in
human serum and colostrum samples were analyzed
using Wilcoxon test. Spearman correlation test was used
to correlate the levels between the same antibody isotype
in different samples or between different antibody iso-
types in the same sample. Values of p < 0.05 were con-
sidered statistically significant.
Results
Detection of antibodies in serum and colostrum samples
from puerperal women
T. gondii-specific IgG, IgM and IgA antibodies were de-
tected by ELISA in 136 (47.0 %), 20 (6.9 %), 8 (2.8 %)
serum samples and in 133 (46.0 %), 23 (7.9 %), 8 (2.8 %)
colostrum samples.
The levels of anti-T. gondii IgG, IgM and IgA anti-
bodies in serum and colostrum from all puerperal
women participating in this study are shown in Fig. 1.
The levels of IgG antibodies detected in colostrum sam-
ples (mean: 5.90; median/range [med]: 5.26/1.22–14.05)
were significantly higher than IgG detected in serum
samples (mean: 4.99; med: 4.66/1.28–8.62), p < 0.0001.
In contrast, the levels of IgM and IgA antibodies de-
tected in colostrum samples (mean: 1.91; med: 1.61/
1.22–5.46 and mean: 1.96, med: 1.65/1.22–4.23, respect-
ively) were significantly lower than IgM and IgA de-
tected in serum samples (mean: 2.87; med: 2.36/1.58–
7.88 and mean: 2.98; med: 2.02/1.22–8.20, respectively),
p < 0.0001.
Correlation between anti-T. gondii antibody levels in
serum and colostrum
When analyzing the anti-T. gondii antibody isotype
levels detected in serum and colostrum samples, a sig-
nificant positive correlation was found when the levels
of IgG were compared (r = 0.7858; p < 0.0001) (Fig. 2a).
A significant positive correlation was also observed when
the levels of IgM were compared (r = 0.4975; p < 0.0001)
(Fig. 2b), whereas, a negative correlation was found when
the levels of IgA were compared (r = −0.2168; p = 0.0002)
(Fig. 2c).
The antibody isotype levels detected in serum samples
showed different degrees of positive correlation, as fol-
lows: IgG vs IgM, low correlation, though it was statisti-
cally significant (r = 0.1674; p = 0.0043) (Fig. 3a); IgG vs
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IgA, low correlation with no statistical significance (r =
0.1038; p = 0.0780) (Fig. 3c); IgM vs IgA, significant cor-
relation (r = 0.6274; p < 0.0001) (Fig. 3e). Regarding the
levels of anti-T. gondii antibody isotypes detected in col-
ostrum samples, positive correlations were found for
IgG vs IgM (r = 0.2124; p = 0.0003) (Fig. 3b) and IgM vs
IgA (r = 0.1765; p = 0.0026) (Fig. 3f ).
Associations among T. gondii-specific IgG, IgM and IgA in
serum and colostrum
Four serum samples and four colostrum samples pre-
sented simultaneous reactivity to T. gondii for all three
analyzed isotypes, with three samples from concordant
patients (60.0 %). Simultaneous reactivity to IgG plus
IgM of two isotypes was observed in serum and colos-
trum (4.2 and 4.5 %, respectively), to IgG plus IgA in
serum and colostrum (0.7 and 0.3 %, respectively), and
to IgM plus IgA in serum and colostrum samples (0.3
and 0.7 %, respectively), with 66.7 % of concordant pa-
tients to IgG plus IgM. The most frequent event was
the reactivity to IgG (40.8 % in serum and 39.8 % in
colostrum) with 94.2 % of concordant patients. As ob-
served in Table 1, 94.1 % of patients had concordant re-
sults for anti-T. gondii antibodies when colostrum and
serum samples were analyzed.
Detection of T. gondii antigenic fractions by specific IgG,
IgM and IgA antibodies
According to the conventional serologic ELISA results,
30 patients were characterized as a risk group of acute
toxoplasmosis since their samples presented IgA and/or
IgM in serum and/or in colostrum associated or not to
presence of IgG. Their samples were selected for im-
munoblotting assays in order to evaluate the detection
Fig. 1 Measurement of anti-T. gondii antibody levels from assorted
isotypes. Levels of IgG, IgM and IgA isotypes directed to the parasite
were detected in serum and colostrum samples from 289 puerperal
women, as determined by ELISA indices (EI). The dashed line represents
the cut-off value (EI = 1.2). *** Data statistically significant
(p < 0.0001, Wilcoxon)
Fig. 2 Correlation between levels of anti-T. gondii antibody from
assorted isotypes. Levels of IgG (a), IgM (b) and IgA (c) antibody
isotypes were compared in serum and colostrum samples from 289
puerperal women. Correlation coefficients were calculated by
Spearman correlation test
Oliveira et al. BMC Infectious Diseases  (2015) 15:519 Page 4 of 13
of the three isotypes of antibodies against various T. gondii
soluble antigens. Samples from one of these patients were
not tested due to insufficient volume.
Immunoblotting assays showed that it is possible to
detect IgG, IgM and IgA antibodies specific to differ-
ent antigen fractions of T. gondii in human serum and
colostrum samples (Fig. 4). Anti-T. gondii IgG present
in serum and colostrum samples recognized a higher
number of antigenic fractions than the IgM and IgA
antibodies specific for the parasite (Fig. 5). Further-
more, we observed that IgG antibodies reacted simi-
larly to at least 20 antigenic fractions (97, 83, 66, 60,
57, 54, 50, 44, 38, 34, 32, 30, 29, 28, 26, 25, 24, 23, 22
and 21 kDa) in more than 75 % of serum samples.
It is different from what was observed in colostrum
samples, where recognition varied highly among pa-
tients with reactivity to at least 14 antigenic fractions
(70, 50, 39, 34, 32, 29, 27, 26, 25, 24, 23, 20, 19 and
15 kDa), with less than 50 % of frequency (Figs. 5a
and 6). However, considering paired serum and colos-
trum samples from the same patient, it was possible to
observe that IgG present in the serum always recog-
nized more T. gondii antigens than IgG antibodies
present in colostrum.
Fig. 3 Correlation between levels of T. gondii-specific antibody isotypes. Samples from serum (a, c, e) or colostrum (b, d, f) were obtained from
289 puerperal women. Correlation coefficients were calculated by Spearman correlation test
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Regarding IgM antibodies, a pattern of recognition of
T. gondii antigenic fractions was observed only in serum
samples, where more than 75 % of the samples reacted
with three fractions (70, 54 and 30 kDa) (Figs. 5b and 6).
The majority of fractions were detected with less than
50 % of frequency for both types of samples. Further-
more, when both biological samples from the same
woman were taken into account, the IgM recognition
profile of antigens also varied.
By analyzing IgA isotype, the profile of reactivity was
opposite to the IgG antibodies. Considering both sam-
ples from the same patient, the colostrum IgA specific
antibodies recognized a higher number of antigenic frac-
tions than the IgA antibodies present in serum. Also, 97,
83 and 70 kDa fractions were recognized in more than
75 % of colostrum samples. However, no similar recogni-
tion pattern was observed in colostrum or serum sam-
ples from many puerperal women, when analyzed
separately, since most antigenic fractions were recog-
nized with frequencies below 50 % (Figs. 5c and 6).
Avidity of IgG antibodies to antigenic fractions of T.
gondii
As shown in Fig. 7, the immunoblotting assay to evalu-
ate avidity of IgG antibodies was carried out with serum
and colostrum samples from 21 out of 30 from puer-
peral patients, including from the risk group. Figure 8
shows the average avidity of IgG antibodies specific for
each antigenic fractions of T. gondii (Fig. 8a), as well as
the frequency of recognition for each fraction by IgG
antibodies of low avidity (Fig. 8b) or high avidity
(Fig. 8c).
All antigenic fractions detected with high frequency
(>75 % samples) by serum IgG antibodies (Fig. 5a) are
recognized by antibodies with high avidity, except for
the 50 and 60 kDa fractions, with 50 % of patients hav-
ing IgG antibodies with high avidity specific for them
(Fig. 8c). In addition, no patient had IgG antibodies
with low avidity in the serum in 22, 30, 32, 38, 54, 57
and 83 kDa fractions (Fig. 8b). Colostrum IgG anti-
bodies showed a lower avidity in almost all antigenic
fractions comparing with the avidity of serum IgG anti-
bodies (Figs. 7 and 8a). Also, 60 and 66 kDa fractions
were frequently recognized by colostrum IgG anti-
bodies of low avidity (Fig. 8b). However, IgG antibodies
of high avidity specific to 60 kDa fraction were not de-
tected (Fig. 8c). On the other hand, 22, 30, 38 and
54 kDa fractions were often recognized by IgG anti-
bodies of high avidity, for both types of biological sam-
ples (Fig. 8c).
Clinical assistance and follow-up
During samples collection all patients received guide-
lines on the importance of breastfeeding, as well as
how to breastfeed and how to hand milk to relieve
engorged breast. In addition, the patients whose immu-
noassays of IgM and/or IgA were positive for T. gondii
were informed, and their children had a follow-up ap-
pointment scheduled with a neonatologist at the Clin-
ical Hospital, UFU. For these newborns, the following
tests were carried out: serology for T. gondii (IgG and
IgM), cranial ultrasonography to evaluate cerebral cal-
cifications and ventriculomegaly as a sign of hydro-
cephalus, and funduscopy examination to evaluate
chorioretinitis. All examinations were performed at the
Clinical Hospital, UFU.
Nine patients did not attend the follow-up appoint-
ment and their children were not evaluated. The other
newborns were examined and followed up for at least six
months after birth to monitor the possibility of congenital
infection. Funduscopy examination and ultrasonography
of the skull showed normal results for most of them,
together with negative IgM and decay of IgG level, indicat-
ing that it was the maternal antibody which was trans-
ferred. However, as shown in Table 2, three newborns
manifested the disease with monitoring and treatment of
the following cases:
Case 1 – During prenatal care the mother was
diagnosed with acute toxoplasmosis in the second
trimester and treated with sulfadiazine, pyrimethamine
and folinic acid until the 34th week of pregnancy, and
with spiramycin until delivery. Neonate presented
positive IgM and IgG, dilatation of the lateral ventricles
of the brain and abnormal fundoscopy, which
characterizes hydrocephalus and chorioretinitis due to
congenital toxoplasmosis infection.
Case 2 – During prenatal care the mother was
diagnosed with acute toxoplasmosis in the second
trimester and treated with spiramycin until the end of
pregnancy. Neonate presented negative IgM and
Table 1 Detection of T. gondii-specific IgG, IgM and IgA isotypes






Concordant patients in serum
and colostruma n (%)
+/+/+ 4 (1.4) 4 (1.4) 3 (60.0)
+/+/- 12 (4.2) 13 (4.5) 10 (66.7)
+/-/+ 2 (0.7) 1 (0.3) 0 (0)
-/+/+ 1 (0.3) 2 (0.7) 1 (50.0)
+/-/- 118 (40.8) 115 (39.8) 113 (94.2)
-/+/- 3 (1.0) 4 (1.4) 1 (16.7)
-/-/+ 1 (0.3) 1 (0.3) 0 (0)
-/-/- 148 (51.3) 149 (51.6) 144 (94.1)
Total 289 (100) 289 (100) 272 (94.1)
aData are presented in number (n) and percentage (%) of the analyzed samples
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positive IgG, multiple cerebral calcifications and
chorioretinitis due to congenital toxoplasmosis
infection.
Case 3 – Neonate presented negative IgM and
increased IgG, normal cranial ultrasonography, but eye
damage diagnosed as chorioretinitis due to congenital
Fig. 4 Immunoblotting results for antigenic fractions from T. gondii. The assay was performed with soluble antigen of T. gondii for detection of
IgG (a), IgM (b) and IgA (c) isotypes directed to the parasites in serum and colostrum samples from puerperal women. Molecular weights (kDa)
are shown at left side. C+ positive control. C- negative control. B blank
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toxoplasmosis. This case deserves emphasis because
during prenatal care the mother was diagnosed as
immune to toxoplasmosis, as only IgG antibodies were
detected at that time. However, our results showed that
in fact she had acute toxoplasmosis in the first days
after delivery, which was confirmed by the detection of
IgM and IgA specific to the parasite in serum and
colostrum samples (Table 2).
Discussion
It is generally accepted that T. gondii infection may cause
severe fetal diseases, when occurring during pregnancy
[2]. This vertical transmission may vary from 6 to 72 %,
depending on the gestational period when it occurs, with
the risk of transmission increasing from the 1st to the 3rd
trimesters in human pregnancy. Among the serious fetal
damages, when the maternal infection takes place during
the 1st trimester of pregnancy, are: decreased eyesight or
blindness, hearing impairment or deafness and mental
problems [17].
Toxoplasma gondii congenital infections are usually
neglected because they are frequently asymptomatic at
birth and may remain overlooked until months or years
after birth [18], when they can emerge, usually as severe
Fig. 5 Reactivity of antibody isotypes towards antigenic fractions from T. gondii. Frequencies (%) of positivity for IgG (a), IgM (b) and IgA (c) in
serum and colostrum samples that recognize each antigenic fraction (kDa) of T. gondii
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Fig. 6 Reactivity pattern of antigenic fractions recognized by IgG, IgM and IgA antibody isotypes. Immunoblotting assays were carried out in serum and
colostrum samples from puerperal women. Data are expressed as range of frequencies (%). A: All antigenic fractions detected in samples. Molecular
weights (kDa) are shown at left side. Different colors represent different pixel density
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chorioretinitis [19]. Hence, it is extremely important to
exclude the possibility of T. gondii infection even at
puerperal period, since the mother may be asymptomati-
cally infected during pregnancy. In the present study, it
was demonstrated that in one of the cases of congenital
toxoplasmosis, the pregnant woman was diagnosed as
immune to toxoplasmosis, but actually she had an acute
infection with T. gondii and her baby had severe ocular
manifestation of the disease.
The production of IgG antibodies is important to con-
trol T. gondii infection, but IgG-producing plasma cells
from breast tissue contribute little to the level of IgG in
Fig. 7 IgG avidity immunoblotting towards antigenic fractions of T. gondii. Representative immunoblotting assay to detect IgG avidity in serum
and colostrum samples directed to soluble antigens of T. gondii. Molecular weights (kDa) are shown at left side. 1 and 2: membrane strips incubated
with serum sample and washed with untreated or 6 M urea-treated preparation, respectively. 3 and 4: membrane strips incubated with colostrum
sample and washed with untreated or 6 M urea-treated preparation, respectively. C+ positive control. C- negative control. B blank
Fig. 8 IgG avidity indices against T. gondii in serum and colostrum samples. The results are expressed in avidity index percentage (AI) towards
T. gondii antigenic fractions. a. Average IgG avidity against each antigenic fraction. b. Frequencies from antigenic fractions recognized with low avidity
(AI < 50 %). c. Frequencies from antigenic fractions recognized with high avidity (AI > 75 %)
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colostrum, when compared to IgG derived from serum
[20, 21]. In the present study, a significant association
between serum and colostrum IgG levels was observed,
indicating that the majority of IgG isotype was trans-
ferred from plasma to mammary gland, explaining the
immunoblotting assay results, which showed that serum
IgG recognized more T. gondii antigenic fractions than
colostrum IgG. In contrast, when the levels of IgA iso-
type were compared between serum and colostrum sam-
ples, a weak association was found. Furthermore, the
immunoblotting assays showed that IgA antibodies
present in colostrum samples recognized a higher num-
ber of antigenic fractions than serum IgA. This is a new
piece of information concerning immune response to
T. gondii, even though it is in agreement with the litera-
ture, which shows that most IgA is synthesized locally
by plasma cells in mammary gland [21].
Chardès and colleagues [22] demonstrated the pres-
ence of T. gondii-specific IgG, IgM and IgA antibody in
serum, intestinal secretions and milk from mice experi-
mentally infected with cysts of the parasite via oral. They
also showed that IgG antibodies present in serum and
milk recognized more antigenic fractions than IgA and
IgM isotypes, and IgG antibodies also detected most of
the antigens recognized by IgA. This is in accordance
with our results for human serum and colostrum sam-
ples described in the present study. However, it is neces-
sary to make clear that there are limitations of this
approach, taking into account the fact that the recogni-
tion of parasite antigenic fractions by different antibody
isotypes depends on the individual immune response of
the patients.
Although 39 kDa antigenic fraction was recognized by
IgG and IgA serum and colostrum antibodies in less
than 25 % if the samples, this fraction was recognized by
IgG serum from all three puerperal mothers whose new-
borns presented clinically confirmed congenital toxo-
plasmosis. In addition, this fraction was also detected by
colostrum IgA from two of these puerperal women.
Thus, these results justify particular attention to deter-
mine the potential role of the 39 kDaT. gondii fraction
as a suitable marker to diagnose congenital toxoplasmo-
sis. Also, the 60 kDa fraction may be considered a good
marker for acute toxoplasmosis infection because it was
recognized frequently by IgG antibodies of low avidity,
mainly in colostrum samples, including from mothers
whose neonates presented vertical infection.
It is known that maternal IgG antibodies play a pro-
tective role in congenital toxoplasmosis, by reducing pla-
cental parasitemia, as well as by their transference to the
fetus through the placenta [18, 23–26]. Our results
showed that colostrum had a high level of specific IgG
antibodies against T. gondii and, therefore, this may be
a source of potentially protective IgG antibodies to
minimize the damage of congenital infection in the
newborn. In agreement with data from literature dem-
onstrating that IgA isotype may remain biologically ac-
tive on mucosal surfaces due to its proteolytic digestion
resistance [27–30], the present study also demonstrated
that human colostrum samples have high levels of IgA
antibodies against T. gondii, providing effective protec-
tion to the child.
Conclusions
The present study demonstrated that it is important to
investigate the occurrence of congenital toxoplasmosis
even at puerperal period, as we showed that T. gondii-
specific IgG, IgM and IgA antibodies may be detected
with significant correlations in serum and colostrum
samples from puerperal women. These results suggest that
colostrum may also be used as an alternative biological
sample to efficiently diagnose congenital toxoplasmosis
and that further studies are necessary to access if the col-
ostrum immunoglobulins specific to T. gondii play a sig-
nificant role in the control of congenital toxoplasmosis.
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